Medicare Enrolled
Dr. Peter Zeman, M.D.
Optician · Wilmington, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zeman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zeman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zeman
Dr. Peter Zeman is an optician specialist in Wilmington, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zeman performed 12,333 Medicare services across 4,905 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zeman received a total of $14,653 from 61 pharmaceutical and/or device companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zeman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NC
$14,653 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,333
Medicare services
Top 4% in NC for optician
4,905
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~617 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,907 | $0 | $3 |
| Leuprolide injectable, camcevi, 1 mg | 1,806 | $66 | $120 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,618 | $3 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,007 | $86 | $199 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
797 | $8 | $20 |
| PSA test (prostate cancer screening) | 766 | $18 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
421 | $59 | $139 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
318 | $132 | $298 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
265 | $8 | $75 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
210 | $25 | $130 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
190 | $22 | $113 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
157 | $174 | $432 |
| New patient office visit, complex (60-74 min) | 118 | $149 | $348 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
83 | $10 | $30 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
83 | $24 | $74 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $117 | $273 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
59 | $44 | $177 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
49 | $75 | $175 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
40 | $166 | $1,650 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
40 | $126 | $350 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
34 | $5 | $201 |
| Injection, garamycin, gentamicin, up to 80 mg | 34 | $2 | $16 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
31 | $45 | $305 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
30 | $74 | $1,200 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
22 | $25 | $350 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
21 | $270 | $680 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
21 | $147 | $350 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
21 | $19 | $73 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
20 | $12 | $106 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
18 | $105 | $384 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
17 | $179 | $455 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
16 | $51 | $95 |
| Hexaminolevulinate hydrochloride instillation, 100 mg Instillation of hexaminolevulinate hydrochloride, 100 mg. |
15 | $970 | $1,300 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
14 | $546 | $2,675 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
12 | $116 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,653
Total received (2018-2024)
Avg $2,093/year across 7 years
Top 10% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
702
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,616 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,388
2023
$3,010
2022
$3,410
2021
$2,081
2020
$1,023
2019
$797
2018
$944
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$1,175
Sumitomo Pharma America, Inc.
$309
PFIZER INC.
$258
Janssen Biotech, Inc.
$243
Bayer Healthcare Pharmaceuticals Inc.
$161
Endo USA, Inc.
$143
Astellas Pharma US Inc
$138
180 Medical, Inc.
$106
UROGEN PHARMA, INC.
$93
Merck Sharp & Dohme LLC
$79
Antares Pharma, Inc.
$79
ABBVIE INC.
$78
Ferring Pharmaceuticals Inc.
$74
PROCEPT BioRobotics Corporation
$59
AstraZeneca Pharmaceuticals LP
$53
IMMUNITYBIO, INC.
$53
Novartis Pharmaceuticals Corporation
$49
COLOPLAST CORP
$44
Boston Scientific Corporation
$40
PROGENICS PHARMACEUTICALS, INC.
$38
Telix Pharmaceuticals
$19
Verity Pharmaceuticals Inc.
$19
Cardinal Health 414 LLC
$18
Smith+Nephew, Inc.
$17
ACCORD HEALTHCARE, INC.
$16
Endo Pharmaceuticals Inc.
$16
AngioDynamics, Inc.
$13
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$4,277
Astellas Pharma US Inc
$1,735
Janssen Biotech, Inc.
$1,244
Sumitomo Pharma America, Inc.
$861
PFIZER INC.
$763
Endo Pharmaceuticals Inc.
$418
Accord Healthcare, Inc.
$329
Myovant Sciences Inc.
$315
UROGEN PHARMA, INC.
$276
180 Medical, Inc.
$271
Amgen Inc.
$268
Bayer HealthCare Pharmaceuticals Inc.
$259
ACCORD HEALTHCARE, INC.
$253
Bayer Healthcare Pharmaceuticals Inc.
$242
Antares Pharma, Inc.
$204
AstraZeneca Pharmaceuticals LP
$183
Merck Sharp & Dohme LLC
$158
UROVANT SCIENCES INC
$158
Blue Earth Diagnostics Limited
$145
Endo USA, Inc.
$143
BOSTON SCIENTIFIC CORPORATION
$141
Teleflex LLC
$127
Myriad Genetic Laboratories, Inc.
$120
Ferring Pharmaceuticals Inc.
$120
ABBVIE INC.
$111
Novartis Pharmaceuticals Corporation
$108
Axonics, Inc.
$90
Boston Scientific Corporation
$89
UroGen Pharma, Inc.
$85
Merck Sharp & Dohme Corporation
$84
AbbVie Inc.
$78
COLOPLAST CORP
$76
PROCEPT BioRobotics Corporation
$73
IMMUNITYBIO, INC.
$53
MEDIVATION FIELD SOLUTIONS LLC
$51
Allergan, Inc.
$50
Sun Pharmaceutical Industries Inc.
$50
AbbVie, Inc.
$49
AngioDynamics, Inc.
$41
Allergan Inc.
$40
Olympus America Inc.
$39
PROGENICS PHARMACEUTICALS, INC.
$38
Palette Life Sciences, Inc.
$38
Hollister Incorporated
$33
Smith+Nephew, Inc.
$32
Supernus Pharmaceuticals, Inc.
$32
Verity Pharmaceuticals Inc.
$31
Augmenix, Inc.
$29
Acerus Pharmaceuticals Corporation
$26
Zyla Life Sciences, Inc.
$26
Laborie Medical Technologies Corp.
$24
Coloplast Corp
$23
Foundation Medicine, Inc.
$21
Medtronic USA, Inc.
$21
Telix Pharmaceuticals
$19
Cardinal Health 414 LLC
$18
AMAG Pharmaceuticals, Inc.
$14
ARGON MEDICAL DEVICES, INC.
$14
Kowa Pharmaceuticals America, Inc.
$13
Photocure Inc
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
Top 3 companies account for 49.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS 700 CXR RTE KIT · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACAnalysis CDx · CAMCEVI · CURE CATHETER · CURE ULTRA CATHETER · CYSVIEW · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL THERAPIES · GENTLECATH · GentleCath · ILLUCCIX · INTERSTIM ICON · INTRAROSA · Infyna Chic · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · LithoVue · Luja Coude · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Nubeqa · ORGOVYX · PLUVICTO · PROVENGE · PVC · PYLARIFY · Prolaris · Prolia · REZUM · SEGLENTIS · SPEEDICATH · SPRIX · STRAVIX · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · TRU-CORE · Titan · Trelstar · UROLIFT · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for optician in NC.
Geographic Context
Opticians within 10 mi
39
Per 100K population
16.9
County median income
$72,892
Nearest hospital
WILMINGTON TREATMENT CENTER
7.1 mi
7.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zeman is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NC), with low-engagement industry engagement in the top 10% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zeman experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Zeman performed 3,907 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zeman receive payments from pharmaceutical companies?
Yes. Dr. Zeman received a total of $14,653 from 61 companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zeman's costs compare to other opticians in Wilmington?
Dr. Zeman's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zeman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Wilmington
Browse opticians in Wilmington ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology